ClinicalTrials.gov
public full text
Public Domain
Genetic Testing to Understand and Address Renal Disease Disparities Across the United States Pharmacogenetic Substudy
This is a substudy of GUARDD-US (Genetic testing to Understand and Address Renal Disease Disparities across the United States, NCT04191824). Its primary purpose is to determine the effect of knowledge of genetic test results that predict efficacy of various antihypertensive medications on change in SBP (systolic blood pressure) from baseline to 3 months in APOL1 (apolipoprotein L1) negative individuals at participating sites.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genetic Testing to Understand and Address Renal Disease Disparities Across the United States#1161608
- A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet#834471
- Clinical Implications of DNA Analysis on ADPKD#1086958
- The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment#877104
- Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study#800607
Record · ID 1336729
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive